FinnCap Lowers Robinson (RBN) Price Target to GBX 130

Robinson (LON:RBN) had its price objective dropped by investment analysts at FinnCap from GBX 135 ($1.87) to GBX 130 ($1.80) in a research note issued to investors on Friday. The brokerage currently has a “corporate” rating on the stock. FinnCap’s price target suggests a potential upside of 55.69% from the company’s previous close.

Robinson (RBN) opened at GBX 83.50 ($1.15) on Friday. Robinson has a 12-month low of GBX 87 ($1.20) and a 12-month high of GBX 141.50 ($1.95). The stock has a market capitalization of $10.71 and a price-to-earnings ratio of 1,670.00.

COPYRIGHT VIOLATION NOTICE: This story was originally published by Ticker Report and is owned by of Ticker Report. If you are reading this story on another domain, it was illegally copied and reposted in violation of US & international copyright law. The legal version of this story can be read at https://www.tickerreport.com/banking-finance/3298576/finncap-lowers-robinson-rbn-price-target-to-gbx-130.html.

About Robinson

Robinson plc is a United Kingdom-based company engaged in the business of manufacturing plastic and paperboard packaging. The Company provides packaging solutions that specialize in injection, blow and stretch-blow molded plastic, and rigid paperboard. It serves the food, drink, toiletries, cosmetic and household markets.

Receive News & Ratings for Robinson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Robinson and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

56,297 Shares in HFF  Purchased by Millennium Management LLC
56,297 Shares in HFF Purchased by Millennium Management LLC
D.B. Root & Company LLC Acquires Shares of 10,296 Qualcomm
D.B. Root & Company LLC Acquires Shares of 10,296 Qualcomm
Canadian National Railway  Price Target Cut to C$112.00 by Analysts at Desjardins
Canadian National Railway Price Target Cut to C$112.00 by Analysts at Desjardins
Metropolitan Life Insurance Co. NY Has $239,000 Stake in Assembly Biosciences
Metropolitan Life Insurance Co. NY Has $239,000 Stake in Assembly Biosciences
Barracuda Networks Inc  Holdings Cut by Metropolitan Life Insurance Co. NY
Barracuda Networks Inc Holdings Cut by Metropolitan Life Insurance Co. NY
Metropolitan Life Insurance Co. NY Sells 3,827 Shares of National Healthcare
Metropolitan Life Insurance Co. NY Sells 3,827 Shares of National Healthcare


© 2006-2018 Ticker Report. Google+.